


GenIP combines human expertise and proprietary GenAI to evaluate and rapidly commercialize new technologies worldwide.





Can AI help identify which inventions have the greatest commercial potential? Our CPO Harin Vaghela discusses how GenIP’s Invention Evaluator combines AI, proprietary data and human expertise. Watch the interview ▶️ youtu.be/cF1PR2mpbS8 #GNIP #AI


👀ICYMI: Have you registered? Join CEO Melissa Cruz & CFO Kevin Fitzpatrick for a live investor webinar and Q&A via CMC CapX Spotlight on 24 September at 17:00 BST. 🎙 Hear directly from management 💬 Submit questions live or in advance ✅Register here: cmccapxspotlight.com/login
Melissa Cruz, CEO and Kevin Fitzpatrick, CFO, will host an investor webinar and Q&A session via @CMCMarkets CapX Spotlight on 24 September 2026 at 17:00 BST. Investors can register for free and join the webinar by clicking below 👇 cmccapxspotlight.com/login


Melissa Cruz, CEO and Kevin Fitzpatrick, CFO, will host an investor webinar and Q&A session via @CMCMarkets CapX Spotlight on 24 September 2026 at 17:00 BST. Investors can register for free and join the webinar by clicking below 👇 cmccapxspotlight.com/login

UBC hit 300 spinouts. Yale's Cloverleaf Bio raised $33M from AbbVie, Lilly & Boehringer Ingelheim. Four levers, one goal: scaling commercialization. genip.ai/news/articles/from-… #TechTransfer





